TABLE 1.
Appointment time | Participants screened | Samples collected | HPV tests | Cytology tests | Colposcopy referrals | CIN2+ detected |
---|---|---|---|---|---|---|
Intervention group | ||||||
Enrollment | 9552 | 9655 | 9655 | 799 | 305 | 98 |
12 months | 532 | 568 | 568 | 561 | 239 | 49 |
24 months | – | – | – | – | – | – |
36 months | – | – | – | – | – | – |
48 months | 8296 | 8700 | 8700 | 8683 | 469 | 48 |
Total | 9552 | 18923 | 18923 | 10043 | 1013 | 195 |
Control group | ||||||
Enrollment | 9457 | 9860 | 89 | 9860 | 279 | 89 |
12 months | 53 | 63 | 0 | 63 | 11 | 1 |
24 months | 8040 | 8333 | 67 | 8333 | 145 | 38 |
36 months | 35 | 35 | 0 | 35 | 2 | 0 |
48 months | 8139 | 8445 | 8445 | 8445 | 513 | 62 |
Total | 9457 | 26727 | 8601 | 26727 | 913 | 190 |
Results are presented for full trial, including 48‐month exit co‐testing.